| 000 | 05479nam a22006495i 4500 | ||
|---|---|---|---|
| 001 | 978-1-0716-3523-0 | ||
| 003 | DE-He213 | ||
| 005 | 20260610083713.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 231208s2024 xxu| s |||| 0|eng d | ||
| 020 |
_a9781071635230 _9978-1-0716-3523-0 |
||
| 024 | 7 |
_a10.1007/978-1-0716-3523-0 _2doi |
|
| 050 | 4 | _aQR355-502 | |
| 072 | 7 |
_aPSGL _2bicssc |
|
| 072 | 7 |
_aSCI099000 _2bisacsh |
|
| 072 | 7 |
_aPSG _2thema |
|
| 082 | 0 | 4 |
_a579.2 _223 |
| 082 | 0 | 4 |
_a616.96 _223 |
| 245 | 1 | 0 |
_aBacteriophage Therapy _h[electronic resource] : _bFrom Lab to Clinical Practice / _cedited by Joana Azeredo, Sanna Sillankorva. |
| 250 | _a2nd ed. 2024. | ||
| 264 | 1 |
_aNew York, NY : _bSpringer US : _bImprint: Humana, _c2024. |
|
| 300 |
_aXI, 321 p. 62 illus., 59 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 341 | 0 |
_bTable of contents navigation _2onix |
|
| 341 | 0 |
_bSingle logical reading order _2onix |
|
| 341 | 0 |
_bShort alternative textual descriptions _2onix |
|
| 341 | 0 |
_bUse of color is not sole means of conveying information _2onix |
|
| 341 | 0 |
_bUse of high contrast between text and background color _2onix |
|
| 341 | 0 |
_bNext / Previous structural navigation _2onix |
|
| 341 | 0 |
_bAll non-decorative content supports reading without sight _2onix |
|
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2734 |
|
| 505 | 0 | _aIsolation of Bacteriophages for Clinically Relevant Bacteria -- Observation of Bacteriophage Ultrastructure by Cryo-electron Microscopy -- Bacteriophage Taxonomy: A Continually Evolving Discipline -- Guidelines to Compose an Ideal Bacteriophage Cocktail -- Rapid Bench to Bedside Therapeutic Bacteriophage Production -- Bacteriophage Production in Compliance with Regulatory Requirements -- Nano/micro formulations for bacteriophage delivery -- Phage-Host Interaction Analysis using Flow Cytometry -- Bacteriophage control of infectious biofilms -- Studying bacteriophage efficacy using a zebrafish model -- Use of Galleria mellonella as an animal model for studying the antimicrobial activity of bacteriophages with potential use in phage therapy -- Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-specific Antibodies -- Bacteriophage Treatment of Infected Diabetic Foot Ulcers -- A Review of Phage Therapy for Bone and Joint Infections -- Successful Use of Phage and Antibiotics Therapy for the Eradication of Two Bacterial Pathogens from the Respiratory Tract of an Infant -- Genetic engineering and rebooting of bacteriophages in L-form bacteria -- Synthetic Biology to Engineer Bacteriophage Genomes -- Genetic engineering of therapeutic phages using Type III CRISPR-Cas systems -- Robust and reproducible protocol for phage genome “rebooting” using transformation-associated recombination (TAR) cloning into yeast centromeric plasmid. | |
| 520 | _aThis highly anticipated second edition details cutting-edge experimental approaches for bacteriophage research. This comprehensive volume details new and updated experimental approaches for isolating, formulating, and engineering bacteriophage medicinal products. Authored by leading experts and written in the highly successful Methods in Molecular Biology series format, each chapter includes introductions to their respective topics, lists of the necessary materials and reagents, step-by-step reproducible laboratory protocols, and valuable tips for troubleshooting and avoiding known pitfalls. Whether you are a seasoned scientist or a newcomer, Bacteriophage Therapy: From Lab to Clinical Practice, Second Edition provides essential tools and knowledge to advance bacteriophage research and its translation into innovative medicinal products and clinical therapies. | ||
| 532 | 8 | _aAccessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | _aNo reading system accessibility options actively disabled | |
| 532 | 8 | _aPublisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | _aVirology. | |
| 650 | 0 | _aBacteria. | |
| 650 | 0 | _aTherapeutics. | |
| 650 | 1 | 4 | _aVirology. |
| 650 | 2 | 4 | _aBacteria. |
| 650 | 2 | 4 | _aTherapeutics. |
| 700 | 1 |
_aAzeredo, Joana. _eeditor. _0(orcid)0000-0002-5180-7133 _1https://orcid.org/0000-0002-5180-7133 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aSillankorva, Sanna. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071635223 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071635247 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071635254 |
| 830 | 0 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2734 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-1-0716-3523-0 |
| 912 | _aZDB-2-PRO | ||
| 999 |
_c8030 _d8030 |
||